Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008

Vaccine

Volumn 28, Issue 39, 2010, Pages 6455-6462

  Khetsuriani, N ^a   Imnadze, P ^b   Baidoshvili, L ^b   Jabidze, L ^b   Tatishili, N ^c   Kurtsikashvili, G ^d   Lezhava, T ^d   Laurent, E ^e   Martin, R ^e  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b National Center for Disease Control and Public Health   (Georgia)

^c Department of Neurology and Epilepsy   (Georgia)

^d WHO Office in Georgia   (Georgia)

^e WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

Author keywords

Adverse events following immunization; European Region; Georgia; Mass immunization campaigns; Measles rubella vaccine; Vaccine safety

Indexed keywords

MEASLES RUBELLA VACCINE;

ACUTE GASTROENTERITIS; ACUTE GLOMERULONEPHRITIS; ADOLESCENT; ADULT; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANXIETY; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONVULSION; DISEASE SEVERITY; DRUG INTOXICATION; DRUG SAFETY; FEMALE; FEVER; GEORGIA (REPUBLIC); HEADACHE; HEALTH PROMOTION; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MASS MEDIUM; MEASLES VACCINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SEIZURE; SIDE EFFECT; SYNCOPE; THROMBOCYTOPENIA; VACCINATION REACTION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; CHILD; GEORGIA (REPUBLIC); HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MEASLES; MEASLES VACCINE; RUBELLA; RUBELLA VACCINE; SYNCOPE; YOUNG ADULT;

EID: 77956420544     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.043     Document Type: Article

References (44)

1. Editorial Team Measles once again endemic in the United Kingdom 2008, Euro Surveillance, 13:1.
2. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention Immunization safety review. Vaccines and autism. Institute of Medicine of the National Academies 2004, The National Academies Press, Washington, DC.
3. Poland G.A., Spier R. Fear, misinformation, and innumerates: how the Wakefield paper, the press, and advocacy groups damaged the public health. Vaccine 2010, 28:2361-2362.
4. EUVAC.NET Report of the 5th annual meeting 2007.
5. CDC Mumps epidemic-United Kingdom, 2004-2005. MMWR Morb Mortal Wkly Rep 2006, 55:173-175.
6. Strebel P., Papania M., Dayan G., Halsey N.A. Measles vaccine. Vaccines 2008, 353-398. Saunders Elsevier Inc. 5th ed. S. Plotkin, W. Orenstein, P. Offit (Eds.).
7. World Health Organization Strategic plan for measles and congenital rubella infection in the WHO European Region 2003, vol. 2009. WHO Regional Office for Europe, Copenhagen, Denmark.
8. CDC Progress toward measles elimination-European Region, 2005-2008. MMWR Morb Mortal Wkly Rep 2009, 58:142-145.
9. Danilova M. Vaccine scare threatens health in Ukraine 2008, Associated Press, Kiev, Ukraine.
10. Doshi S., Khetsuriani N., Zakhashvili K., Baidoshvili L., Imnadze P., Uzicanin A. Ongoing measles and rubella transmission in Georgia, 2004-05: implications for the national and regional elimination efforts. Int J Epidemiol 2009, 38:182-191.
11. Spika J.S., Wassilak S., Pebody R., et al. Measles and rubella in the World Health Organization European Region: diversity creates challenges. J Infect Dis 2003, 187(Suppl. 1):S191-S197.
12. Cornell S.E., Starr S.F. The Guns of August 2008: Russia's war in Georgia (studies of central Asia and the Caucasus) 2009, M.R. Sharpe Inc., pp. 1-304.
13. Edwards I.R., Biriell C. Harmonisation in pharmacovigilance. Drug Safety 1994, 10:93-102.
14. Global Advisory Committee on Vaccine Safety Causality assessment of adverse events following immunization. Wkly Epidemiol Rec 2001, 76:85-89.
15. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 2000, Washington, DC, American Psychiatric Association, pp. 429-483.
16. CDC Measles, Mumps, and Rubella-vaccine use and strategies for elimination of Measles, Rubella, and congenital Rubella syndrome and control of Mumps: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1998, 47(RR-8):1-57.
17. Institute of Medicine Measles and mumps vaccines. Adverse events associated with childhood vaccines. Evidence bearing on causality 1994, 118-186. National Academy Press, Washington, DC. K.R. Stratton, C.J. Howe, R.B. Johnston (Eds.).
18. Institute of Medicine Evidence concerning rubella vaccines and arthritis, radiculoneuritis, and thrombocytopenic purpura. Adverse effects of pertussis and rubella vaccines 1991, 187-205. National Academy Press, Washington, DC. C.P. Howson, C.J. Howe, H.V. Fineberg (Eds.).
19. Clements C.J. Gardasil and mass psychogenic illness. Aust N Z J Public Health 2007, 31:387.
20. D'Argenio P., Citarella A., Intorcia M., Aversano G. An outbreak of vaccination panic. Vaccine 1996, 14:1289-1290.
21. Boss L.P. Epidemic hysteria: a review of the published literature. Epidemiol Rev 1997, 19:233-243.
22. CDC Syncope after vaccination-United States, January 2005-July 2007. MMWR Morb Mortal Wkly Rep 2008, 57:457-460.
23. Khiem H., Huan L., Phuong N.T.M., et al. Mass psychogenic illness following oral cholera immunization in Ca Mau City, Vietnam. Vaccine 2003, 21:4527-4531.
24. Peiro E.F., Yanez J.L., Carraminana I., Rullan J.V., Castell J. Study of an outbreak of hysteria after hepatitis B vaccination. Med Clin 1996, 107:1-3.
25. Kharabsheh S., Al-Otoum H., Clements J., et al. Mass psychogenic illness following tetanus-diphtheria toxoid vaccination in Jordan. Bull World Health Organ 2001, 79:764-770.
26. Clements C.J. Mass psychogenic illness after vaccination. Drug Saf 2003, 26:599-604.
27. Yasamy M.T., Bahramnezhad A., Ziaaddini H. Postvaccination mass psychogenic illness in an Iranian rural school. East Mediterr Health J 1999, 5:710-716.
28. Pless R.P., Bentsi-Enchill A.D., Duclos P. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues. J Infect Dis 2003, 187(Suppl. 1):S291-S298.
29. Nemery B., Fischler B., Boogaerts M., Lison D., Dioxins Coca-Cola, and mass sociogenic illness in Belgium. Lancet 1999, 354:77.
30. Radovanovic Z. On the origin of mass casualty incidents in Kosovo, Yugoslavia, in 1990. Eur J Epidemiol 1996, 12:101-113.
31. Modan B., Swartz T.A., Tirosh M., et al. The Arjenyattah epidemic. A mass phenomenon: spread and triggering factors. Lancet 1983, 2:1472-1474.
32. Landrigan P.J., Miller B. The Arjenyattah epidemic. Home interview data and toxicological aspects. Lancet 1983, 2:1474-1476.
33. Barron R.A., Leaning J., Rumack B.H. The catastrophe reaction syndrome: trauma in Tbilisi. Int J Law Psychiatry 1993, 16:403-426.
34. Leaning J., Barron R., Rumack B. Bloody Sunday: trauma in Tbilisi. the events of April 9, 1989 and their aftermath. Report of a medical mission to Soviet Georgia 1990, Physicians for Human Rights, Cambridge, Massachussetts.
35. National Center for Disease Control and Public Health Mass immunization campaign against measles and rubella in Georgia (September 29-October 12, 2008). Guidelines for health care providers 2008, National Center for Disease Control and Public Health, Tbilisi, Georgia.
36. Kasperson R., Kasperson J. The Social amplification and attenuation of risk. Ann Am Acad Pol Soc Sci 1996, 545:95-104.
37. May T. Public communication, risk perception, and the viability of preventive vaccination against communicable diseases. Bioethics 2005, 19:407-421.
38. Hefez A. The role of the press and the medical community in the epidemic of " mysterious gas poisoning" in the Jordan West Bank. Am J Psychiatry 1985, 142:833-837.
39. Petts J., Niemeyer S. Health risk communication and amplification: learning from the MMW vaccination controversy. Health Risk Soc 2004, 6:7-23.
40. The Institute of Polling and Marketing Baseline survey: COMBI-immunization plan for Georgia. Report 2007, UNICEF/Georgia, Tbilisi, Georgia.
41. United Nations prequalified vaccines. WHO list of vaccines for purchase by UN agencies as of March 2010. Available at: <>http://www.who.int/immunization_standards/vaccine_quality/pq_suppliers/en/.
42. Tavares Barros de Carvalho M, Mattos Bulhoes M, Viera da Rocha CM, Flannery B. Brazil: vaccination campaign to eliminate rubella. Immunization newsletter. Panamerican Health Organization 2009; XXXI:1:pp. 3-4.
43. Khetsuriani N., Music S., Deforest A., Sutter R.W. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions. J Infect Dis 2000, 181(Suppl. 1):S208-S212.
44. Keshishian C. Mass psychogenic illness and how to respond to incidents. Chem Hazard Poisons Rep 2008, 13:22-24.